T Cell Activation Markers and African Mitochondrial DNA Haplogroups among Non-Hispanic Black Participants in AIDS Clinical Trials Group Study 384

• Todd Hulgan ,

  * E-mail: todd.hulgan@vanderbilt.edu

  Affiliation Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Gregory K. Robbins,

  Affiliation Massachusetts General Hospital/Harvard University, Boston, Massachusetts, United States of America

  ⨯
• Spyros A. Kalams,

  Affiliation Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• David C. Samuels,

  Affiliation Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Benjamin Grady,

  Affiliation Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Robert Shafer,

  Affiliation Stanford University Medical Center, Stanford, California, United States of America

  ⨯
• Deborah G. Murdock,

  Affiliation Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Doug Selph,

  Affiliation Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• David W. Haas,

  Affiliation Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Richard B. Pollard, for the AIDS Clinical Trials Group

  Membership of the AIDS Clinical Trials Group is provided in the Acknowledgments.

  Affiliation University of California Davis, Sacramento, California, United States of America

  ⨯